EASTSIDE DISTILLING INC (EAST)

US2778024016 - Common Stock

0.8015  0 (-0.2%)

After market: 0.7704 -0.03 (-3.88%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EAST. EAST was compared to 32 industry peers in the Beverages industry. EAST may be in some trouble as it scores bad on both profitability and health. EAST is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

EAST had negative earnings in the past year.
EAST had a negative operating cash flow in the past year.
In the past 5 years EAST always reported negative net income.
EAST had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -47.82%, EAST is doing worse than 93.10% of the companies in the same industry.
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROIC N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of EAST (8.90%) is worse than 93.10% of its industry peers.
EAST's Gross Margin has declined in the last couple of years.
EAST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%

0

2. Health

2.1 Basic Checks

EAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EAST has been increased compared to 5 years ago.
Compared to 1 year ago, EAST has an improved debt to assets ratio.

2.2 Solvency

EAST has an Altman-Z score of -8.78. This is a bad value and indicates that EAST is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.78, EAST is doing worse than 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.78
ROIC/WACCN/A
WACC5.88%

2.3 Liquidity

A Current Ratio of 0.29 indicates that EAST may have some problems paying its short term obligations.
With a Current ratio value of 0.29, EAST is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
EAST has a Quick Ratio of 0.29. This is a bad value and indicates that EAST is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.18, EAST is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.18

6

3. Growth

3.1 Past

EAST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.90%, which is quite impressive.
EAST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.85%.
EAST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%

3.2 Future

EAST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.51% yearly.
Based on estimates for the next years, EAST will show a very strong growth in Revenue. The Revenue will grow by 30.21% on average per year.
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

EAST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EAST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EAST's earnings are expected to grow with 26.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.94%
EPS Next 3Y26.51%

0

5. Dividend

5.1 Amount

No dividends for EAST!.
Industry RankSector Rank
Dividend Yield N/A

EASTSIDE DISTILLING INC

NASDAQ:EAST (1/14/2025, 8:00:01 PM)

After market: 0.7704 -0.03 (-3.88%)

0.8015

0 (-0.2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners9.75%
Inst Owner Change0%
Ins Owners5.01%
Ins Owner Change10.1%
Market Cap3.76M
Analysts82.86
Price Target3.57 (345.41%)
Short Float %4.42%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.54%
Min EPS beat(2)-4.02%
Max EPS beat(2)39.1%
EPS beat(4)1
Avg EPS beat(4)-65.98%
Min EPS beat(4)-247.59%
Max EPS beat(4)39.1%
EPS beat(8)3
Avg EPS beat(8)-64.89%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-31.7%
Min Revenue beat(2)-75.73%
Max Revenue beat(2)12.33%
Revenue beat(4)1
Avg Revenue beat(4)-40.8%
Min Revenue beat(4)-75.73%
Max Revenue beat(4)12.33%
Revenue beat(8)1
Avg Revenue beat(8)-37.64%
Revenue beat(12)3
Avg Revenue beat(12)-23.56%
Revenue beat(16)3
Avg Revenue beat(16)-23.95%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.45
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS1.36
BVpS-0.52
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.9%
FCFM N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.18
Altman-Z -8.78
F-Score3
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)66.85%
Cap/Depr(5y)70.3%
Cap/Sales(3y)7.35%
Cap/Sales(5y)8.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A
EBIT growth 1Y22.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.9%
EBIT Next 3Y46.83%
EBIT Next 5YN/A
FCF growth 1Y69.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.7%
OCF growth 3YN/A
OCF growth 5YN/A